Search

Your search keyword '"Limbert, M."' showing total 176 results

Search Constraints

Start Over You searched for: Author "Limbert, M." Remove constraint Author: "Limbert, M."
176 results on '"Limbert, M."'

Search Results

2. Minimum standards of pelvic exenterative practice:PelvEx Collaborative guideline

3. Simultaneous pelvic exenteration and liver resection for primary rectal cancer with synchronous liver metastases: results from the PelvEx Collaborative

4. Management strategies for patients with advanced rectal cancer and liver metastases using modified Delphi methodology: results from the PelvEx Collaborative

5. Contemporary management of locally advanced and recurrent rectal cancer: views from the PelvEx collaborative

8. The impact of the COVID-19 pandemic on the Management of Locally Advanced Primary/Recurrent Rectal Cancer

9. Predicting outcomes of pelvic exenteration using machine learning

10. Perioperative management and anaesthetic considerations in pelvic exenterations using Delphi methodology: results from the PelvEx Collaborative

11. Perioperative management and anaesthetic considerations in pelvic exenterations using Delphi methodology: results from the PelvEx Collaborative

12. Combined liver resection and cytoreductive surgery with HIPEC for metastatic colorectal cancer: Results of a worldwide analysis of 565 patients from the Peritoneal Surface Oncology Group International (PSOGI)

13. Combined liver resection and cytoreductive surgery with HIPEC for metastatic colorectal cancer: Results of a worldwide analysis of 565 patients from the Peritoneal Surface Oncology Group International (PSOGI)

16. Simultaneous pelvic exenteration and liver resection for primary rectal cancer with synchronous liver metastases: results from the PelvEx Collaborative

17. Predicting outcomes of pelvic exenteration using machine learning

18. The global cost of pelvic exenteration:in-hospital perioperative costs

19. Chemoradiation with capecitabine and mitomycin-C for locally advanced anal squamous cell carcinoma: experience of a single Portuguese institution

23. ENDOSCOPIC RESPONSE TO CHEMORADIOTHERAPY IN LOW RECTAL CANCER: ARE THE WAIT-AND-SEE CRITERIA TOO STRICT?

26. Long-hole plug: addressing the hazard of bogged rods in upholes.

34. RU 29 246, the active compound of the cephalosporin-prodrug-ester HR 916. I. Antibacterial activity in vitro

35. RU 29 246, the active compound of the cephalosporin prodrug-ester HR 916. III. Pharmacokinetic properties and antibacterial activity in vivo

36. Comparative chemotherapeutic activity of cefpirome and imipenem in experimental infections

39. RU 29 246, the active compound of the cephalosporin-prodrug-ester HR 916. II. Stability to beta-lactamases and affinity for penicillin-binding proteins

Catalog

Books, media, physical & digital resources